Clinical trial
Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With…
NCT00136773 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00136773 |
|---|---|
| Title | Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus |
| Official title | Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Albuminuria |
| Intervention type | Drug |
| Interventions | amlodipine/benazepril |
| Enrollment | 332 |
| Start date | Apr 1, 2003 |
| Primary completion | Oct 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Aug 29, 2005 |
| Last update posted | Mar 9, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: